Merrill Matthews, Ph.D., is a resident scholar with the Institute for Policy Innovation, a research-based, public policy “think tank.” He is a health policy expert and opinion contributor at The Hill. He also serves on the Texas Advisory Committee of the U.S. Commission on Civil Rights.
Dr. Matthews is a past president of the Health Economics Roundtable for the National Association for Business Economics, the largest trade association of business economists. Dr. Matthews also served for 10 years as the medical ethicist for the University of Texas Southwestern Medical Center’s Institutional Review Board for Human Experimentation, co-author of On the Edge: America Faces the Entitlements Cliff, and has contributed chapters to several books, including Physician Assisted Suicide: Expanding the Debate and The 21st Century Health Care Leader and Stop Paying the Crooks (on Medicare fraud).
He has been published in numerous journals and newspapers, including The Wall Street Journal, Investor’s Business Daily, Barron’s, USA Today, Forbes magazine and the Washington Times. He was an award-winning political analyst for the USA Radio Network.
Dr. Matthews received his Ph.D. in Humanities from the University of Texas at Dallas.
Direct-to-Consumer Drug Advertising Benefits Companies, but Patients Even More
Advertising is a way companies convey important information to consumers about products that may help them. The return on investment isn't just to drug companies, it's to people who act on that important medical information.
A Guide to Understanding Prescription Drug Pricing
President Trump and many in Congress want to reduce prescription drug prices. This paper discusses how drug prices are determined and explains why political efforts to reduce them would be both harmful and counterproductive.
Global Capitalists Meet in Davos to Extol Global Socialism
At least some World Economic Forum attendees think we have reached "peak laissez-faire," meaning it's time to give government more control over our economies and our liberties.
A Balanced Assessment of the U.S.- China Trade Deal
One of the president's top trade advisors sees nothing but positives from imposing tariffs. A more balanced view sees some positives, but many negatives.
The Carbon Credit Scheme: Greenhouse Gas Credits Don't Help the Environment--Or Consumers
To stay in business, car manufacturers have to please consumers—not the government. And consumers still want gas-powered cars.
Exodus from Blue States Continues--and Grows
The Blue-State Exodus Gains Momentum
It was only a matter of time before both businesses and individuals began voting with their feet. And that time has apparently come.
Middle East Tensions Drive Gas Prices...Nowhere?
Who could imagine 10 years ago that the Middle East could be in chaos and it would have virtually no impact on gasoline prices? Welcome to the age of fracking.
Regarding Healthcare, GOP Faces Biggest Hurdle
Voters will have a lot on their minds when they go to the polls next year. Resident scholar Merrill Matthews thinks 2020 will be a referendum on healthcare policy.
Total Records: 1735
